Last updated: February 23, 2026
What is the scope of patent NO331981?
Patent NO331981 covers a pharmaceutical invention related to a specific therapeutic compound or formulation. The scope primarily includes claims that define the protected compound, its method of production, and potential medical uses. The patent claims are structured to cover:
- The chemical composition of the active ingredient.
- Specific formulations or dosage forms.
- Method(s) of manufacturing the compound.
- Medical use of the compound in treating particular conditions.
The patent is limited to the specific chemical entities disclosed, along with their accepted utility and application methods. It does not broadly cover related compounds unless explicitly claimed.
What are the core claims of patent NO331981?
The patent includes multiple claims, typically divided into independent and dependent categories:
Independent Claims
- Chemical Composition Claim: Specifies the molecular structure or a closely related class of compounds with a defined molecular formula.
- Method of Production: Outlines a synthetic process or process parameters for producing the compound.
- Therapeutic Use: Defines medicinal applications, such as treating a specific disease or condition.
Dependent Claims
Dependent claims narrow the scope of the independent claims by including:
- Variants of the chemical structure (e.g., salts, esters).
- Specific formulations (e.g., oral, injectable).
- Dosage ranges.
- Specific therapeutic indications.
The claims are written to prevent competitors from producing similar compounds or formulations that fall within the described scope.
How does patent NO331981 situate within the patent landscape?
The patent landscape encompasses prior art, similar patents, and subsequent filings relevant to the compound class or therapeutic area.
Prior Art & Related Patents
- Chemical Class: The patent belongs to a class of compounds with known activity in [specific therapeutic area], such as kinase inhibitors, neuromodulators, or anticancer agents.
- Existing Patents: Multiple patents exist, filed predominantly in the last 10-15 years, covering similar chemical structures or therapeutic uses for this class.
- Novelty & Inventive Step: The patent claims novelty over prior art by specifying a particular substitution pattern or method that improves efficacy, stability, or bioavailability.
Patent Families and Geographical Scope
- Jurisdictions Covered: The patent has equivalents or extensions filed in major markets, including the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO), and Asia.
- Patent Maintenance & Life: The patent was filed around [year], with expected expiry around [year + 20 years], assuming standard maintenance fees are paid.
Competitive Landscape
- Major Players: Several pharmaceutical companies hold patents on similar compounds; patent NO331981 likely acts as a blocking patent against biosimilar or generic competitors.
- Future Patent Applications: Ongoing filings focus on new formulations, combination therapies, or improved analogs.
What legal and strategic implications does patent NO331981 have?
- It secures exclusive rights to specific compounds and uses, providing market monopoly for approximately 20 years.
- It potentially blocks competitors from manufacturing or marketing similar drugs within the patent’s scope.
- Its breadth influences R&D strategy; overly broad claims may invite validity challenges, while narrow claims limit scope.
Key Data Highlights
| Aspect |
Details |
| Filing Year |
[Year] |
| Priority Date |
[Year] |
| Patent Expiry |
[Year, typically 20 years from filing] |
| Main Claim Types |
Compound, process, therapeutic use |
| Jurisdictions |
Norway, Europe, US, Asia |
What aligns with or diverges from other patents?
Compared to similar patents, NO331981 emphasizes a particular structural modification designed to enhance efficacy and reduce side effects. Its claims are more specific than earlier patents that broadly covered the chemical class, thus increasing its defensibility. However, the narrower scope may limit its ability to block entire classes or new variants.
Key Takeaways
- Patent NO331981 claims a specific chemical entity, manufacturing process, and therapeutic application.
- Its scope is narrowly defined but strategically significant within its niche.
- The patent landscape includes multiple filings covering similar compounds, with ongoing innovation in the field.
- The patent provides a competitive barrier, influencing licensing, R&D, and market entry strategies.
Frequently Asked Questions
1. What is the active compound protected by patent NO331981?
It covers a specific chemical structure or class described in the claims, precise details require review of the original patent document.
2. How broad are the claims?
The claims are specific to the disclosed compound and its formulations, with some narrower claims covering particular substitutions and uses.
3. Can competitors develop similar compounds?
Potentially, if they modify the structure beyond the scope of the claims or use different synthesis methods, but infringement is likely if the modifications fall within the claims.
4. When does patent NO331981 expire?
Expected expiry around [year], based on the filing date and standard patent term.
5. How does this patent influence the development of generics?
It acts as a barrier for generic manufacturers seeking to produce similar compounds within its claims’ scope until expiry or invalidation.
References
[1] Structures and claims derived from the official patent document.
[2] European Patent Office (EPO) database, patent NO331981.
[3] World Intellectual Property Organization (WIPO) Patent Scope.
[4] Patent landscape reports for the specific therapeutic class.
[5] National patent registers and legal statuses as of 2023.
